Antonio M. Jr. Gotto

Antonio M. Jr. Gotto's AcademicInfluence.com Rankings

Philosophy

#3872

World Rank

#6179

Historical Rank

Logic

#1470

World Rank

#2231

Historical Rank

philosophy Degrees

Antonio M. Jr. Gotto

Biology

#4937

World Rank

#7290

Historical Rank

Biochemistry

#548

World Rank

#636

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Antonio M. Jr. Gotto Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Antonio M. Jr. Gotto's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. (1992) (1212)
A molecular theory of lipid—protein interactions in the plasma lipoproteins (1974) (582)
Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. (1978) (447)
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. (1978) (433)
Human plasma lipoprotein [a]. Structural properties. (1983) (421)
Introduction to the plasma lipoproteins. (1986) (392)
High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. (1987) (385)
Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. (1983) (381)
Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100 (1986) (380)
Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. (1980) (354)
Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. (1975) (336)
Triglyceride, high density lipoprotein, and coronary heart disease. (1993) (335)
Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. (1984) (315)
The plasma lipoproteins: structure and metabolism. (1978) (300)
Lipoprotein structure and metabolism. (1976) (296)
Relationship of Plasma Lipoprotein Lp(a) Levels to Race and to Apolipoprotein B (1985) (275)
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. (1973) (274)
Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism. (1979) (254)
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. (2000) (245)
Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. (1984) (239)
Lipid-protein interactions in the plasma lipoproteins. (1977) (230)
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. (1993) (214)
Lipoproteins: structure and function. (1975) (209)
Characterization of human high density lipoproteins by zonal ultracentrifugation. (1980) (192)
Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. (1982) (188)
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. (1999) (185)
The complete cDNA and amino acid sequence of human apolipoprotein B-100. (1986) (183)
Kinetics of lipid--protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. (1978) (182)
Structure of Apolipoprotein B‐100 of Human Low Density Lipoproteins (1989) (182)
Levels of Soluble Cell Adhesion Molecules in Patients With Dyslipidemia (1996) (181)
Transforming Growth Factor-β1 (TGF-β1) and TGF-β2 Decrease Expression of CD36, the Type B Scavenger Receptor, through Mitogen-activated Protein Kinase Phosphorylation of Peroxisome Proliferator-activated Receptor-γ* (2000) (168)
Digital imaging fluorescence microscopy: spatial heterogeneity of photobleaching rate constants in individual cells (1985) (159)
Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. (1986) (157)
Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. (1977) (150)
Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. (1990) (148)
Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. (1983) (143)
Biological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases. (2013) (143)
Three-dimensional structure of low density lipoproteins by electron cryomicroscopy. (1999) (136)
Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. (1984) (133)
The influence of lipid on the conformation of human plasma high density apolipoproteins. (1972) (126)
On the protein defect in abetalipoproteinemia. (1971) (121)
Primary structure of very low density apolipoprotein C-II of human plasma. (1977) (112)
Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. (1995) (111)
A comparative study on the removal of cellular lipids from Landschütz ascites cells by human plasma apolipoproteins. (1975) (110)
Novel Polymorphisms in Promoter Region of ATP Binding Cassette Transporter Gene and Plasma Lipids, Severity, Progression, and Regression of Coronary Atherosclerosis and Response to Therapy (2001) (106)
Kinetics and mechanism of the spontaneous transfer of fluorescent phosphatidylcholines between apolipoprotein-phospholipid recombinants. (1982) (106)
Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. (1972) (106)
Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells. (1979) (105)
Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteins. (1984) (101)
Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia. (1978) (100)
Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts. (1982) (99)
A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma. (1989) (98)
The metabolism of C2 compounds in micro-organisms. 6. Synthesis of cell constituents from glycollate by Pseudomonas sp. (1961) (97)
Localization Patterns of Plasma Apolipoproteins in Human Atherosclerotic Lesions (1975) (95)
Plasma lipid and lipoprotein response of humans to beef fat, coconut oil and safflower oil. (1985) (93)
Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regions. (1979) (92)
The role of dietary polyunsaturated fat in lowering blood cholesterol in man. (1978) (91)
Plasma metabolism of apolipoprotein A-IV in humans. (1986) (91)
Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. (1991) (91)
Metabolism of normal and modified low-density lipoproteins by macrophage cell lines of murine and human origin. (1985) (90)
Quantification of apoC-II and apoC-III of human very low density lipoproteins by analytical isoelectric focusing. (1978) (89)
Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein. (1972) (89)
Bovine serum albumin. Study of the fatty acid and steroid binding sites using spin-labeled lipids. (1975) (89)
Different reactivities of high density lipoprotein2 subfractions with hepatic lipase. (1992) (88)
Kinetics of lipid--protein interactions: effect of cholesterol on the association of human plasma high-density apolipoprotein A-I with L-alpha-dimyristoylphosphatidylcholine. (1979) (88)
Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. (1994) (87)
The primary structure of apolopoprotein-serine. (1974) (86)
Human liver fatty acid binding protein cDNA and amino acid sequence. Functional and evolutionary implications. (1985) (83)
Lecithin:cholesterol acyltransferase. Functional regions and a structural model of the enzyme. (1987) (83)
Isolation and characterization of sulfhydryl and disulfide peptides of human apolipoprotein B-100. (1990) (81)
Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. (1992) (81)
Inhibitory effects of hypercholesterolemia and ox-LDL on angiogenesis-like endothelial growth in rabbit aortic explants. Essential role of basic fibroblast growth factor. (1997) (77)
The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). II. The amino acid sequence and alignment of cyanogen bromide fragments IV, III, and I. (1975) (76)
Apolipoprotein/lipid interactions: studies with synthetic polypeptides. (1982) (76)
Pitavastatin Downregulates Expression of the Macrophage Type B Scavenger Receptor, CD36 (2004) (76)
Localization of low-density lipoproteins in atherosclerotic lesions from human normolipemics employing a purified fluorescent-labeled antibody. (1974) (75)
A comparison of the major apolipoprotein from pig and human high density lipoproteins. (1973) (74)
Murine macrophage tumors are a source of a 260,000-dalton acetyl-low density lipoprotein receptor. (1985) (74)
PHOSPHOLIPID BINDING STUDIES WITH SYNTHETIC APOLIPOPROTEIN FRAGMENTS * (1980) (73)
The primary structure of high density apolipoprotein-glutamine-I. (1974) (70)
Relationship of hypertriglyceridemia to atherosclerosis. (1981) (69)
Influence of short term dietary cholesterol and fat on human plasma Lp[a] and LDL levels. (1991) (68)
Apolipoprotein B Retention in the Grossly Normal and Atherosclerotic Human Aorta (1977) (68)
Oxidized Low Density Lipoprotein Decreases Macrophage Expression of Scavenger Receptor B-I* (2001) (68)
The in vitro interaction of human apolipoprotein A-I and high density lipoproteins. (1977) (66)
Human apolipoprotein B: analysis of internal repeats and homology with other apolipoproteins. (1987) (66)
Dynamic properties of human high density lipoprotein apoproteins. (1978) (65)
Isolation, chemical characterization, and biophysical properties of three different abnormal lipoproteins: LP-X1, LP-X2, and LP-X3. (1977) (64)
Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. (2002) (63)
Effect of saturated and polyunsaturated fat diets on the composition and structure of human low density lipoproteins (1980) (62)
Abnormal effects of hypertriacylglycerolemic very low-density lipoproteins on 3-hydroxy-3-methylglutaryl-CoA reductase activity and viability of cultured bovine aortic endothelial cells. (1980) (62)
The measurement of apolipoprotein A-I in human plasma by electroimmunoassay. (1980) (62)
The antigenic structure of apolipoprotein A-I in human high density lipoproteins. Radioimmunoassay using surface-specific antibodies. (1980) (62)
Effect of cholesterol feeding on the distribution of plasma lipoproteins and on the metabolism of apolipoprotein E in the rabbit. (1983) (61)
Kinetics and mechanism of the spontaneous transfer of fluorescent phospholipids between apolipoprotein-phospholipid recombinants. Effect of the polar headgroup. (1982) (61)
Quantification of Apolipoprotein B in Grossly Normal Human Aorta (1977) (61)
Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCL in vitro. (1997) (61)
Properties of a new glyoxylate reductase from leaves. (1962) (61)
Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men. (1990) (60)
Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II. (1979) (60)
Chapter 4 Lipoprotein(a): structure, metabolism and epidemiology (1987) (60)
Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. (1993) (59)
Origin of apolipoprotein A-I polymorphism in plasma. (1985) (58)
The interaction of apolipoprotein-serine with phosphatidylcholine. (1974) (58)
Functional Interplay Between the Macrophage Scavenger Receptor Class B Type I and Pitavastatin (NK-104) (2004) (58)
Correlation of apolipoprotein B retention with the structure of atherosclerotic plaques from human aortas. (1978) (57)
Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide. (1980) (57)
Metabolism of apolipoproteins A‐I and A‐ll and its influence on the high density lipoprotein subfraction distribution in males and females (1978) (56)
Lipoproteins in atherosclerotic lesions. Localization by immunofluorescence of apo-low density lipoproteins in human atherosclerotic arteries from normal and hyperlipoproteinemics. (1975) (55)
Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. (1986) (55)
Stimulatory effects of inosine and deoxyinosine on the incorporation of uracil-2-14-C, 5-fluorouracil-2-14-C, and 5-bromouracil-2-14-C into nucleic acids by Ehrlich ascites tumor cells in vitro. (1969) (54)
Human high density lipoprotein, apolipoprotein glutamine II. The immunochemical and lipid-binding properties of apolipoprotein glutamine II derivatives. (1973) (54)
Role of thyroid hormones in apolipoprotein A-I gene expression in rat liver. (1990) (54)
Effect of sucrose diet on apolipoprotein biosynthesis in rat liver. Increase in apolipoprotein E gene transcription. (1989) (53)
Dynamics of lipid-protein interactions. Interaction of apolipoprotein A-II from human plasma high density lipoproteins with dimyristoylphosphatidylcholine. (1980) (53)
A comparison of two methods to investigate the metabolism of human apolipoproteins A-I and and A-II. (1978) (53)
Structure of the dimyristoylphosphatidylcholine vesicle and the complex formed by its interaction with apolipoprotein C-III: X-ray small-angle scattering studies. (1979) (53)
Apolipoprotein B metabolism in normal, type IV and type V hyperlipoproteinemic subjects. (1980) (53)
Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line Published, JLR Papers in Press, July 16, 2003. DOI 10.1194/jlr.M300084-JLR200 (2003) (52)
Manual of Lipid Disorders: Reducing the Risk for Coronary Heart Disease (2002) (51)
The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5' homologous sequences among apolipoprotein genes. (1985) (51)
Serum lipoprotein structure: resonance energy transfer localization of fluorescent lipid probes. (1980) (51)
No severe bottleneck during human evolution: evidence from two apolipoprotein C-II deficiency alleles. (1991) (51)
A study of the cystine-containing apolipoprotein of human plasma high density lipoproteins: characterization of cyanogen bromide and tryptic fragments. (1972) (50)
Very low density lipoprotein. Removal of Apolipoproteins C-II and C-III-1 during lipolysis in vitro. (1979) (50)
Structure of bovine milk lipoprotein lipase. (1989) (50)
Incorporation of defined cholesteryl esters into lipoproteins using cholesteryl ester-rich microemulsions. (1982) (50)
Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells (2003) (50)
Manual of lipid disorders (1992) (49)
Interaction of phosphatidylcholine and apolipoprotein-alanine: electron microscopic studies. (1973) (49)
Activation of peroxisome proliferator-activated receptor-α in mice induces expression of the hepatic low-density lipoprotein receptor (2008) (49)
The conformational properties of human plasma apolipoprotein C-II. A spectroscopic study. (1980) (49)
High-density lipoproteins, reverse cholesterol transport and atherogenesis (2021) (49)
Lipid binding by fragments of apolipoprotein C-III-1 obtained by thrombin cleavage. (1977) (48)
Action of lipoprotein lipase on phospholipid monolayers. Activation by apolipoprotein C-II. (1983) (48)
Apo B concentration in the normal human aorta. (1978) (48)
The requirement for lipid fluidity in the formation and structure of lipoproteins: thermotropic analysis of apolipoprotein-alanine binding to dimyristoyl phosphatidylcholine. (1974) (47)
Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences. (1982) (47)
Immunochemistry of human plasma high density lipoproteins. Radioimmunoassay of apolipoprotein A-II (1975) (47)
Stimulation and suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase in normal human fibroblasts by high density lipoprotein subclasses. (1980) (46)
Interrelationship of triglycerides with lipoproteins and high-density lipoproteins. (1990) (46)
ACTIVATION OF LIPOPROTEIN LIPASE BY SYNTHETIC FRAGMENTS OF APOLIPOPROTEIN C‐II * (1980) (46)
Physical properties of the dimyristoylphosphatidylcholine vesicle and of complexes formed by its interaction with apolipoprotein C-III. (1977) (45)
Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties. (1979) (45)
Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase. (1996) (45)
Mechanism of lipid-protein interaction in the plasma lipoproteins: lipid-binding properties of synthetic fragments of apolipoprotein A-II. (1977) (44)
Development of cholesterol homeostatic memory in the rat is influenced by maternal diets. (1990) (44)
Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links. (1994) (44)
Effect of saturated and unsaturated fat diets on molecular species of phosphatidylcholine and sphingomyelin of human plasma lipoproteins. (1981) (44)
Low density lipoproteins reconstituted with steroids containing the nitrobenzoxadiazole fluorophore. (1981) (43)
Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. (1994) (42)
Trends in plasma cholesterol levels in the atherosclerosis risk in communities (ARIC) study. (2000) (42)
Partially Reassembled High Density Lipoproteins: Effects on Cholesterol Flux, Synthesis, and Esterification in Normal Human Skin Fibroblasts (1986) (42)
Kinetics of spontaneous and plasma-stimulated sphingomyelin transfer. (1982) (41)
Influence of dietary trans-fatty acids on swine lipoprotein composition and structure. (1977) (41)
Fluorescence assay of the specificity of human plasma and bovine liver phospholipid transfer proteins. (1985) (41)
Isolation and characterization of the cyanogen bromide fragments from the high-density apolipoprotein glutamine I. (1973) (41)
The human apolipoprotein B-100 gene: a highly polymorphic gene that maps to the short arm of chromosome 2. (1985) (41)
Effects of Intravenous Phospholipid on Low Density Lipoprotein Turnover in Man * (1976) (40)
Action of lecithin:cholesterol acyltransferase on model lipoproteins. Preparation and characterization of model nascent high density lipoprotein. (1982) (40)
The metabolism of C2 compounds in micro-organisms. 7. Preparation and properties of crystalline tartronic semialdehyde reductase. (1961) (40)
Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. (2000) (40)
Chemical synthesis and biochemical properties of peptide fragments of apolipoprotein-alanine. (1973) (40)
Pseudohomozygous type II hyperlipoproteinemia. (1974) (39)
Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. (1985) (39)
Dietary cholesterol absorption, and sterol and bile acid excretion in hypercholesterolemia-resistant white rabbits. (1990) (38)
Structure of the major complex formed by interaction of phosphatidylcholine bilamellar vesicles and apolipoprotein-alanine (APO-C-III). (1974) (38)
Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-I in women. (1986) (37)
Effect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma. (1988) (37)
Binding of apoA-IV-phospholipid complexes to plasma membranes of rat liver. (1986) (37)
Action of lipoprotein lipase on mixed triacylglycerol/phosphatidylcholine monolayers. Activation by apolipoprotein C-II. (1983) (37)
Lateral distribution of phospholipid and cholesterol in apolipoprotein A-I recombinants. (1985) (36)
Development and partial metabolic characterization of a dietary cholesterol-resistant colony of rabbits. (1989) (36)
Correlation in the human aorta of APO B fractions with tissue cholesterol and collagen content. (1979) (36)
Human plasma high density lipoprotein. Interaction of the cyanogen bromide fragments from apolipoprotein glutamine II (A-II) with phosphatidylcholine. (1973) (35)
Co-clustering and internalization of low-density lipoproteins and alpha 2-macroglobulin in human skin fibroblasts. (1982) (35)
Effect on saturated and unsaturated fat diets on lipid profiles of plasma lipoproteins. (1982) (35)
Determination of cysteine on low-density lipoproteins using the fluorescent probe, 5-iodoacetamidofluoresceine. (1990) (34)
Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. (2009) (34)
Associations of allelic differences at the A-I/C-III/A-IV gene cluster with carotid artery intima-media thickness and plasma lipid transport in hypercholesterolemic-hypertriglyceridemic humans. (1994) (33)
Suppression of 3-hydroxy-3-methylglutaryl-CoA reductase by low density lipoproteins produced in vitro by lipoprotein lipase action on nonsuppressive very low density lipoproteins. (1979) (33)
Observations on the conformation of human beta lipoprotein: evidence for the occurrence of beta structure. (1968) (33)
Apolipoprotein E: phospholipid binding studies with synthetic peptides from the carboxyl terminus. (1992) (33)
Structure of an apolipoprotein-phospholipid complex: apoC-III induced changes in the physical properties of dimyristoylphosphatidylcholine. (1976) (33)
Genetic Deletion of Low Density Lipoprotein Receptor Impairs Sterol-induced Mouse Macrophage ABCA1 Expression (2008) (33)
High-density lipoprotein cholesterol, plasma triglyceride, and coronary heart disease: pathophysiology and management. (1995) (32)
Isolation and characterization of the human apolipoprotein A-II gene. Electron microscopic analysis of RNA:DNA hybrids, nucleotide sequence, identification of a polymorphic MspI site, and general structural organization of apolipoprotein genes. (1985) (32)
Thermodynamics of lipid-protein association. The free energy of association of lecithin with reduced and carboxymethylated apolipoprotein A-II from human plasma high density lipoprotein. (1981) (31)
Chapter 7 Metabolism of high density lipoproteins (1987) (31)
Interaction of plasma "arginine-rich" apolipoprotein with dimyristoylphosphatidylcholine. (1977) (31)
Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins. (2018) (31)
ABCA1-Derived Nascent High-Density Lipoprotein–Apolipoprotein AI and Lipids Metabolically Segregate (2017) (31)
Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1). (1997) (30)
Postprandial lipemia: reliability in an epidemiologic field study. (1992) (30)
Lipoprotein-apoprotein exchange in aqueous systems: relevance to the occurrence of apoA-I and apoC proteins in a common particle. (1978) (30)
Characterization of baboon plasma high-density lipoproteins and of their major apoproteins. (1977) (30)
Identification of the lipid-binding cyanogen bromide fragment from the cystine-containing high density apolipoprotein, APOLP-GLN-II. (1972) (30)
Formation of high density lipoprotein 2-like particles during lipolysis of very low density lipoproteins in vitro ( lipoprotein lipase / apolipoproteins / lipoprotein lipids / ultracentrifugation ) (30)
Induction of CD 36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-g (2000) (30)
Quantitation of apo B in human aortic fatty streaks. A comparison with grossly normal intima and fibrous plaques. (1978) (29)
The structure and properties of human beta-lipoprotein and beta-apoprotein. (1968) (29)
Role of thyroid hormone in the expression of apolipoprotein A-IV and C-III genes in rat liver. (1993) (29)
Detergent extraction of tightly-bound apoB from extracts of normal aortic intima and plaques. (1978) (29)
Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester (2017) (29)
The cyanogen bromide peptides of the apoprotein of low density lipoprotein (ApoB): its molecular weight from a chemical view. (1978) (29)
Physical properties of lipid-protein complexes formed by the interaction of dimyristoylphosphatidylcholine and human high-density apolipoprotein A-II. (1981) (29)
Effect of Growth Substrates on Isocitratase Formation by Pseudomonas Ovalis Chester (1958) (28)
Binding of the chemical carcinogen, p‐dimethylaminoazobenzene, by human plasma low density lipoproteins (1979) (28)
Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma. (1989) (28)
Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia. (1977) (27)
The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). I. The amino acid sequence of cyanogen bromide fragment II. (1975) (27)
A simplified approach to resonance energy transfer in membranes, lipoproteins and spatially restricted systems. (1983) (27)
The effect of triphasic oral contraceptives on plasma lipids and lipoproteins. (1989) (27)
Contrasting Effects on Plasma Lipoproteins of Intravenous Versus Oral Administration of a Triglyceride‐Phospholipid Emulsion (1975) (26)
Isolation of a helical, lipid-binding fragment from the human plasma high density lipoprotein, apoLP GLN-I. (1972) (26)
Solid phase radioimmunoassay of apolipoprotein B (apo B) in normal human plasma. (1976) (26)
High-density lipoproteins: biochemical and metabolic factors. (1983) (25)
Lipid-peptide association and activation of lecithin:cholesterol acyltransferase. Effect of alpha-helicity. (1986) (25)
Helical amphipathic moment: application to plasma lipoproteins (1983) (25)
The solid phase synthesis of a protein activator for lecithin-cholesterol acyltransferase corresponding to human plasma apoC-I. (1976) (25)
Influence of an atherogenic diet on the structure of swine low density lipoproteins. (1980) (25)
Human serum beta-lipoprotein: preparation and properties of a delipidated, soluble derivative. (1968) (25)
Apolipoprotein E-mediated binding of hypertriglyceridemic very low density lipoproteins to isolated low density lipoprotein receptors detected by ligand blotting. (1986) (24)
Observations on the conformation of human serum high-density lipoproteins using infrared spectroscopy, circular dichroism, and electron spin resonance. (1970) (24)
Mechanism of lipid-protein interaction in the plasma lipoproteins: identification of a lipid-binding site in apolipoprotein A-II. (1981) (24)
Structure and Dynamics of Human Plasma Lipoproteins (1983) (23)
Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method. (1989) (23)
Phospholipids in biology and medicine (first of two parts). (1974) (23)
Cholesteryl ester-rich microemulsions: stable protein-free analogs of low density lipoproteins. (1982) (23)
Apolipoprotein A-II: chemical synthesis and biophysical properties of three peptides corresponding to fragments in the amino-terminal half. (1979) (23)
In vivo interaction of synthetic acylated apopeptides with high density lipoproteins in rat. (1986) (22)
Thyroid Hormone Influences the Maturation of Apolipoprotein A-I Messenger RNA in Rat Liver (*) (1995) (22)
Recent studies on the structure of human serum low-and high-density lipoproteins. (1969) (22)
In vitro binding of synthetic acylated lipid-associating peptides to high-density lipoproteins: effect of hydrophobicity. (1984) (22)
A comparaive study of the effects of chemical modification on the immunochemical and optical properties of human plasma low-density lipoprotein(s) and apoproteins. (1973) (22)
Chapter 3 Lipid-protein interactions and lipoprotein reassembly (1987) (22)
Thermodynamics of lipid-protein association. Enthalphy of association of apolipoprotein A-II with dimyristoylphosphatidylcholine-cholesterol mixtures. (1984) (21)
Blood cholesterol screening in several environments using a portable, dry-chemistry analyzer and fingerstick blood samples. Lipid Research Clinics Cholesterol Screening Study Group. (1990) (21)
Lecithin:cholesterol acyltransferase activation and lipid binding by synthetic fragments of apolipoprotein C-I. (1978) (21)
Circular dichroic studies of human plasma retinol-binding protein and prealbumin. (1972) (21)
The primary structure of apolipoprotein A-I from rabbit high-density lipoprotein. (1986) (20)
STUDIES ON THE PRIMARY STRUCTURE OF APOLIPOPROTEIN B * (1980) (20)
Basal and Postprotein Insulin and Glucagon Levels During a High and Low Carbohydrate Intake and Their Relationships to Plasma Triglycerides (1975) (20)
Spontaneous and plasma factor-mediated transfer of pyrenyl cerebrosides between model and native lipoproteins. (1985) (20)
Identification of peptides containing tryptophan, tyrosine, and phenylalanine using photodiode-array spectrophotometry. (1985) (19)
Monoclonal antibodies against bovine milk lipoprotein lipase. Characterization of an antibody specific for the apolipoprotein C-II binding site. (1985) (19)
Comparative studies on plasma low density lipoproteins from pig and man. (1976) (19)
The primary structure of human apolipoprotein A-IV. (1989) (19)
Effect of blood collection and processing on radioimmunoassay results for apolipoprotein A-I in plasma. (1988) (19)
Apolipoprotein E: phospholipid binding studies with synthetic peptides containing the putative receptor binding region. (1985) (19)
Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health. (2019) (19)
Hydrolysis of phospholipids by purified milk lipoprotein lipase. Effect of apoprotein CII, CIII, A and E, and synthetic fragments. (2000) (19)
Apolipoproteins: pathophysiology and clinical implications. (1996) (19)
Separation of apolipoproteins-a-i and a-ii by ion-paired reversed-phase high-performance liquid chromatography (1981) (19)
Lipoprotein Lipase Interaction with Synthetic N-Dansyl Fragments of Apolipoprotein C-II. (1982) (19)
Application of electron spin resonance to the study of the structure of human serum lipoproteins. (1969) (19)
Effect of sucrose diet on expression of apolipoprotein genes A-I, C-III and A-IV in rat liver. (1992) (19)
Human plasma high density apolipoprotein A-I: effect of protein-protein interactions on the spontaneous formation of a lipid-protein recombinant. (1981) (19)
Conformational properties of human and rat apolipoprotein A-IV. (1985) (19)
Does body fatness modify the effect of dietary cholesterol on serum cholesterol? Results from the Chicago Western Electric Study. (1993) (18)
Composition-structure-function correlations in the binding of an apolipoprotein to phosphatidylcholine bilayer mixtures. (1977) (18)
Primary structure of apoB-100. (1994) (18)
Interaction of apolipoprotein[a] with apolipoproteinB-100 Cys3734 region in lipoprotein[a] is confirmed immunochemically (1996) (17)
Conformation of Human Serum High Density Lipoprotein and its Peptide Components (1969) (17)
Application of laser self-beat spectroscopic technique to the study of solutions of human plasma low-density lipoproteins. (1973) (17)
Phospholipids in biology and medicine (second of two parts). (1974) (17)
Thermodynamics of lipid-protein association and the activation of lecithin:Cholesterol acyltransferase by synthetic model apolipopeptides (1984) (17)
Hypertriglyceridemia: lipoprotein receptors and atherosclerosis. (1985) (17)
High density lipoprotein interconversions in rat and man as assessed with a novel nontransferable apolipopeptide. (1993) (17)
Thermodynamics of lipid protein associations. Thermodynamics of helix formation in the association of high density apolipoprotein A-I (apoA-I) to dimyristoyl phosphatidylcholine. (1977) (16)
Lipoprotein-X: proton and phosphorus-31 nuclear magnetic resonance studies on native, reconstituted, and model systems. (1980) (16)
Interaction of synthetic N-5-dimethylaminonaphthalene-1-sulfonyl-apolipoprotein C-II peptides with lipoprotein lipase. (1983) (16)
Mouse macrophage receptor for acetylated low density lipoprotein: demonstration of a fully functional subunit in the membrane and with purified receptor. (1992) (16)
Identification of proapoa-I in rat lymph and plasma: metabolic conversion to "mature" apoA-I. (1983) (16)
Contribution of alpha helix formation in human plasma apolipoproteins to their enthalpy of association with phospholipids. (1979) (16)
Monoclonal antibodies as probes of high-density lipoprotein structure: identification and localization of a lipid-dependent epitope. (1987) (15)
Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia. (1996) (15)
Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimens. (1993) (15)
Reassembled model lipoproteins. Lipid dynamics in recombinants of human apolipoprotein A-II and dimyristoylphosphatidylcholine. (1981) (15)
Effects of dietary saturated and polyunsaturated fat on the metabolism of apolipoproteins A-I and B. Study of a patient with type IIb hyperlipoproteinaemia. (1978) (15)
Interaction of apoliprotein C-III with phosphatidylcholine vesicles. Dependence of aproprotein-phospholipid complex formation on vesicle structure. (1977) (15)
Basic fibroblast growth factor reverses atherosclerotic impairment of human coronary angiogenesis-like responses in vitro. (1995) (15)
Esterase-type of activity possessed by human plasma apolipoprotein C-II and its synthetic fragments. (1983) (14)
Lipoprotein‐X: a substrate for lecithin: cholesterol acyltransferase (1977) (14)
NUCLEOSIDE METABOLISM IN EHRLICH ASCITES TUMOR CELLS: PHOSPHOROLYSIS OF PURINE NUCLEOSIDES. (1964) (14)
Cholesterol metabolism in hypercholesterolemia-resistant rabbits. (1991) (14)
New Insights into the High-Density Lipoprotein Dilemma (2016) (14)
Digital imaging fluorescence microscopy. (1986) (14)
Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles. (1996) (13)
The mechanism of lipid-binding by plasma lipoproteins (2005) (13)
Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability. (2019) (13)
The phospholipid-binding and immunochemical properties of amidinated, guanidinated and acetylated apolipoprotein A-II. (1980) (13)
Locating a low density lipoprotein-targeting domain of human apolipoprotein B-100 by expressing a minigene construct in transgenic mice. (1991) (13)
Magnetic resonance studies of apolipoprotein C-I nitroxide labeled or [13C]methyl enriched at methionine-38. (1980) (13)
The application of an improved solid phase synthetic technique to the delineation of an antigenic site of apolipoprotein A-II (1983) (13)
Enhanced catabolism of low density lipoproteins in rat by lactosaminated Fab fragment. A new carrier of macromolecules to the liver. (1986) (12)
The hyperlipoproteinemias. (1989) (12)
Metabolism of apolipoprotein A-IV in rat. (1989) (12)
Does body fatness modify the association between dietary cholesterol and risk of coronary death? Results from the Chicago Western Electric Study. (1992) (12)
Workshop on apolipoprotein quantification. (1983) (12)
Isolation and analysis of renal bismuth inclusions. (1965) (12)
Proapolipoprotein A-I conversion kinetics in vivo in human and in rat. (1985) (12)
Structure of Apolipoprotein B100 of Human Low Density Lipoproteins (2005) (11)
Partial delipidation of human serum β-lipoprotein by sodium decyl sulfate (1969) (11)
A laser spectrofluorimeter for studies of cultured cells on the growth surface. (1979) (11)
Plasma catabolism of human apolipoprotein E isoproteins: lack of conversion of the doubly sialylated form to the asialo form in plasma. (1986) (11)
Setting the course for apoAII: a port in sight? (2013) (11)
Isolation and characterization of the murine macrophage acetyl LDL receptor (1982) (11)
Immunochemistry of human very low density lipoproteins: apolipoprotein C-III. (1980) (11)
Thermodynamics of lipid-protein interactions: Interaction of apolipoprotein A-II from human plasma high-density lipoproteins with dimyristoylphosphatidylcholine. (1981) (11)
5-(dimethylamino)naphthalene-1-sulfonic acid, a fluorescent probe of the medium chain fatty acid binding site of serum albumin. (1982) (11)
Electron spin resonance studies of lipid-protein interaction in human serum lipoproteins. (1970) (11)
Thermodynamics of lipid--protein associations: the enthalpy of binding of Apo C-III to synthetic phosphatidylcholines. (1981) (11)
Induction of fructose-1,6-diphosphatase activity in Escherichia coli. (1962) (11)
Primary sequence mapping of human apolipoprotein B-100 epitopes. Comparisons of trypsin accessibility and immunoreactivity and implication for apoB conformation. (1988) (11)
DYNAMICS OF LIPID MOTIONS IN HIGH‐DENSITY LIPOPROTEIN SUBFRACTIONS HDL2 AND HDL3: MAGNETIC RESONANCE STUDIES (1980) (11)
Pitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cells. (2009) (10)
Plasma lipid transport in the preruminant calf, Bos spp: primary structure of bovine apolipoprotein A-I. (1992) (10)
Effects of maleylation on the lipid-binding and immunochemical properties of human plasma high density apolipoprotein-A-II. (1974) (9)
Rapid modulation of rat adipocyte lipoprotein lipase: effect of calcium, A23187 ionophore, and thrombin. (1989) (9)
Interaction of human plasma apolipoproteins and phospholipids. Semi-quantitative studies using polyacrylamide gel electrophoresis. (1975) (9)
Abnormal interaction of the human apolipoprotein A-I variant [Lys107----0] with high density lipoproteins. (1985) (9)
Spectrophotometric and manometric studies of NADPH and NADH oxidase activities of rat liver microsomes: effects of drugs and adenine nucleotides. (1965) (9)
Human Serum Beta-Lipoprotein (1968) (9)
Evidence that apoB-100 of low-density lipoproteins is a novelsrc-related protein kinase (1995) (9)
Crystalline tartronic semialdehyde reductase from Pseudomonas ovalis Chester. (1961) (9)
Determination of the molecular mass of apolipoprotein B-100. A chemical approach. (1986) (9)
Thermodynamics of lipid-protein association in human plasma lipoproteins. (1982) (9)
The metabolism of purine compounds in Ehrlich ascites tumor cells: evidence for a salvage pathway of inosine metabolism. (1967) (8)
Mechanism of lipid--protein interaction in the plasma lipoproteins: relationship of lipid-binding sites to antigenic sites in apolipoprotein A-II. (1979) (8)
Alcohol: A Nutrient with Multiple Salutary Effects (2015) (8)
Launching of an American Medical College in the Middle East: Educational Challenges in a Multicultural Environment (2013) (8)
Chapter 2 The complete structures of human apolipoprotein B-100 and its messenger RNA (1987) (8)
Isolation and assay of the Ac-LDL receptor. (1986) (8)
Speciated High-Density Lipoprotein Biogenesis and Functionality (2016) (8)
The helical hydrophobic moment avoids prolines in phospholipid-binding proteins. (1986) (8)
Cholesterol metabolism in fibroblasts from rabbits resistant to diet-induced hypercholesterolemia. (1990) (7)
Lipoprotein-X: carbon-13 nuclear magnetic resonance studies on native, reconstituted, and model systems. (1980) (7)
Enhanced hepatic uptake and processing of cholesterol esters from low density lipoprotein by specific lactosaminated Fab fragments. (1991) (7)
Pitavastatin Differentially Modulates MicroRNA-Associated Cholesterol Transport Proteins in Macrophages (2016) (7)
Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism. (2015) (7)
Cholesterol: Can't Live With It, Can't Live Without It. (2019) (7)
A review of the unique features of HDL apoproteins (1979) (7)
Human Serum Beta Lipoprotein and Beta Apoprotein (1969) (7)
Immunoreactivity of apolipoprotein B-100 in oxidatively modified low density lipoprotein. (1994) (7)
Transgenic mice expressing full-length human apolipoprotein B-100. Full-length human apolipoprotein B mRNA is essentially not edited in mouse intestine or liver. (1992) (7)
Effect of hydrostatic pressure on the transfer of a fluorescent phosphatidylcholine between apolipoprotein-phospholipid recombinants (1984) (6)
[49] Tartronic semialdehyde reductase (crystalline) (1966) (6)
The Alcohol–High-Density Lipoprotein Athero-Protective Axis (2020) (6)
Human Plasma Lipoprotein Metabolism (2009) (6)
Oxandrolone and plasma triglyceride reduction: effect on triglyceride-rich and high density lipoproteins. (1981) (6)
Kinetics and mechanism of transfer of synthetic model apolipoproteins. (1988) (6)
The Primary Structure of Apolipoprotein-Serine * (2003) (6)
In vitro transfer of phosphatidylcholines and their ether analogs by a human and rat plasma exchange factor. (1984) (6)
Kinetics of tryptic hydrolysis as a probe of the structure of human plasma apolipoprotein A-II. (1989) (6)
Apo-lipoprotein localization in human atherosclerotic arteries. (1976) (6)
Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein CIl ( solid-phase peptide synthesis / plasma triglycerides / lipoproteins ) (6)
Tangier disease in a black patient: an unusual clinical presentation. (1990) (5)
Lipids and Cardiovascular Disease: Putting It All Together. (2019) (5)
Molecular Association of Lipids and Proteins in the Plasma Lipoproteins: A Review (1976) (5)
On the mechanism of the nucleoside stimulation of amino acid incorporation into protein of Ehrlich ascites tumor cells in vitro. (1967) (5)
Targeting CD36: Modulating inflammation and atherogenesis (2003) (5)
Evaluation of the classical methods for the diagnosis of type III hyperlipoproteinemia (1977) (5)
High-Density Lipoprotein Processing and Premature Cardiovascular Disease. (2015) (5)
Plasma lipid transport in the hedgehog: partial characterization of structure and function of apolipoprotein A-I. (1995) (5)
The interaction of apolipoprotein-alanine (apoC-III) with lipids: study of structural features required for binding. (1975) (5)
Release of low density lipoprotein receptors from human fibroblasts or HeLa cells by tryptic digestion. (1978) (5)
High Free Cholesterol Bioavailability Drives the Tissue Pathologies in Scarb1−/− Mice (2021) (5)
Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein[a], and transplantation arteriopathy. (1994) (5)
Separation of the apoprotein components of human very low density lipoproteins by ion-paired, reversed-phase high performance liquid chromatography (1981) (5)
CD36, the Macrophage Class B Scavenger Receptor: Regulation and Role in Atherosclerosis (2001) (5)
Cyclopentanoid analogs of dipalmitoyl phosphatidic acid: effect of backbone geometry on thermotropic properties. (1990) (5)
Identification of a detergent-solubilized plasma membrane protein from rat liver recognizing apolipoprotein A-IV. (1990) (4)
Neo High-Density Lipoprotein Produced by the Streptococcal Serum Opacity Factor Activity against Human High-Density Lipoproteins Is Hepatically Removed via Dual Mechanisms. (2016) (4)
Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo. (2016) (4)
Lactosaminated Fab fragments specific for low density lipoproteins/hepatocyte targeting and hypolipoproteinemic activity. (1988) (4)
The removal of cellular lipids from Landschůtz ascites cells and smooth muscle cells in culture. (1976) (4)
Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits. (1991) (4)
A complex Hind III polymorphism in the human apolipoprotein-B gene (APOB). (1987) (3)
APOA-I and APOA-II Metabolism and Coronary Artery Disease (1987) (3)
Effects of HDL subclasses on 3-hydroxy-3-methylglutaryl coenzyme A reductase in human fibroblasts. (1980) (3)
Protein synthesis in ascites tumor cells: Enhancement by nucleotides and nucleosides (1964) (3)
Studies of the Protein Defect in Tangier Disease (1970) (3)
The influence of dietary-fat saturation on the metabolism of apolipoproteins A-I, B and C in a type IIb hyperlipoproteinaemic subject (1978) (3)
Insulin (I), glucagon (G), and the I/G ratio in carbohydrate (CHO) induced hyperlipemia (1974) (3)
Plasma lipoproteins: recent developments. (1977) (3)
Expression of LDL Receptor Binding Determinants in Very Low Density Lipoproteins a (1985) (3)
Structure of the Plasma Lipoproteins — A Review (1977) (3)
Meeting Summary Relationship of Hypertriglyceridemia to Atherosclerosis (2005) (3)
Effects of nucleosides and nucleoside phosphates on the incorporation of amino acids into proteins of ascites carcinoma cells. Abstr. (1963) (2)
High prevalence of the ApoE Arg145Cys dyslipidemia at-risk polymorphism in African-derived populations (2012) (2)
Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia ( triglycerides / chylomicrons / apolipoproteins / exercise / fat tolerance ) (2)
Drugs affecting lipid metabolism X : proceedings of the Xth International Symposium on Drugs Affecting Lipid Metabolism, Houston, Texas, November 8-11, 1989 ; chairman, Antonio M. Gotto, Jr., and Rodolfo Paoletti (1990) (2)
Regulation of Peroxisome Proliferator-activated Receptor-γ-mediated Gene Expression (2002) (2)
Inflammatory Networks Linking Cardiovascular Disease, Diabetes, and Cancer (2017) (2)
Familial hypercholesterolemia: diagnosis, metabolic defect and management. (1977) (2)
High density lipoproteins and atherosclerosis : proceedings of the Third Argenteuil Symposium held under the auspices of the Fondation cardiologique Princesse Liliane in Waterloo, Belgium on November 7-8, 1977 (1978) (2)
8 – Plasma Lipoproteins and 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase: A Status Report (1985) (2)
Effects of saturated and polyunsaturated fat diets on the chemical and physical properties of lipoproteins from type V hyperlipoproteinemic subjects. (1980) (2)
Workshop Report: Clinical-Pathological Section (1980) (2)
Lipid—Protein Interactions in Human Plasma High Density Lipoproteins* (1974) (1)
The Effects of Lipid Lowering Drugs on the Concentration and Composition of Plasma Lipoproteins in Hyperlipoproteinemias: Changes of VLDL Subfraction and HDL@@@特に, TG-rich リポ蛋白の subfraction の変化とHDLの変化について (1979) (1)
Digital fluorescence imaging microscopy: Analysis of fluorescent lipophiles in cultured cells and in human arterial sections (1988) (1)
Methods for studying lipid-protein interactions. (1973) (1)
Structure and Function of the Human Plasma Apolipoproteins (1980) (1)
The Conformational Properties of Human Plasma Apolipoprotein CI 1 (2001) (1)
Prevention and treatment of atherosclerotic vascular disease: Hypolipidemic agents (2015) (1)
A Metabolic Model for the Hypolipidemic and Antiatherogenic Effects of N-3 Fatty Acids: Effect of Omacor on Plasma Lipids (1996) (1)
Classification and structure of lipoproteins (1985) (1)
A new fluorometric method for measuring the action of C apolipoproteins on milk lipoprotein lipase. (1997) (1)
Flow Mediated Endothelium-Dependent Vasodilation (1996) (1)
Plasma lipoproteins and atherosclerosis in man: an immunohistochemical study. (1973) (1)
Discussion—Effects of pharmacologic intervention on high-density lipoproteins (1983) (1)
Activation of Lipoprotein Lipase by Synthetic Fragments of ApoC-II (1980) (1)
Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials. (2023) (1)
Radioimmunoassay of rat apolipoprotein A-IV. (1986) (1)
Workshop: Plasma Lipoproteins (1974) (1)
Preparation and properties of an apoprotein derivative of human serum beta-lipoprotein. (1968) (1)
SYMPOSIUM ON PLASMA LIPOPROTEINS Presented before the Academy on April 28, 1969 By Invitation of the Committee on Arrangements for the Annual Meeting (1)
Apolipoprotein AIV A DETERMINANT FOR BINDING AND UPTAKE OF HIGH DENSITY LIPOPROTEINS BY RAT (2001) (1)
Erratum: Action of lipoprotein lipase on phospholipid monolayers. Activation by apolipoprotein C-II (Biochemistry (1983) 22, 9, (2270-2275)) (1984) (1)
Abstract 102: Profound Exclusion of Apolipoprotein A-II from Selective Hepatic Cholesteryl Ester Uptake (2013) (1)
The Use of Radially-Compressed Reversed Phase HPLC for the Separation of Tryptic Peptides of Apolipoproteins (1982) (0)
Experimental and Clinical Evidence for a Protective Role of High-Density Lipoprotein in Coronary Heart Disease (1993) (0)
Abstract 326: Streptococcal Serum Opacity Factor Product, Cholesteryl Ester Rich Particles, Induce Cholesterol Ester Metabolism and Bile Acid Secretion after Uptake by Human Huh7 Hepatocytes (2015) (0)
Corrections - Action of Lipoprotein Lipase on Phospholipid Monolayers. Activation by Apolipoprotein C-II (1984) (0)
Erratum: Transgenic mice expressing full-length human apolipoprotein B- 100. Full-length human apolipoprotein B mRNA is essentially not edited in mouse intestine or liver (Journal of Biological Chemistry (1992) 267 (21412- 21420)) (1993) (0)
A STUDY OF LIPID-PROTEIN BINDING BY ELECTROPHORETIC LASER DOPPLER SPECTROSCOPY (1976) (0)
Guest reviewers for volume 2 of the Journal of Behavioral Medicine (2004) (0)
Three-dimensional structure of low density lipoproteins by electron cryomicroscopy (apolipoprotein B-100ylipidystatistical image analysisyangular reconstitution) (1999) (0)
Structure and conformation of the plasma apolipoproteins (1990) (0)
Rethinking Reverse Cholesterol Transport (2018) (0)
Role of Apolipoprotein E and B Gene Variation in Determining Response of Lipid, (2006) (0)
Inverse relationship between blood lipoprotein subfraction 2 and magn postprandial lipemia (triglycerides/chylomicrons/apolipoproteins/exercise/fat tolerance) (2016) (0)
Excess HDL free cholesterol bioavailability drives free cholesterol accretion into macrophages and erythrocytes in SCRAB1-/- mice. (2021) (0)
OBSERVATIONS ON THE CONFORMATION OF HUMAN BET'A LIPOPROTEIN: EVIDENCE FOR THE OCCURRENCE OF BETA STRUCTURE BY A. MI. GoTTo, (0)
Abstract MP30: Excess HDL Free Cholesterol Bioavailability Drives Free Cholesterol Accretion Into Macrophages And Erythrocytes In Scarb1 -/- Mice (2021) (0)
Brain peptides : a new endocrinology : proceedings of the Fourth Argenteuil Symposium held under the auspices of the Fondation Cardiologique Princesse Liliane in Waterloo, Belgium, October 29-31, 1978 (1979) (0)
Factors influencing the course of myocardial ischemia : proceedings of the Seventh Argenteuil Symposium held under the auspices of the Fondation cardiologique Princesse Liliane in La Hulpe, Belgium, June 10 and 11, 1982 (1983) (0)
The high density lipoproteins. (1982) (0)
Activity of a streptococcal cholesterol-lowering protein vs. hdl from apo a-i-deficient mice in vitro and in vivo (2014) (0)
Abstract 113: Streptococcal Serum Opacity Factor Activity Diverts Human High Density Lipoprotein (HDL)-Cholesteryl Esters (CE) to the LDL-Receptor Pathway in Human Huh7 Hepatocytes (2013) (0)
Abstract 499: Serum Opacity Factor Therapy Alters Plasma, Erythrocyte And Tissue Cholesterol Content In The Dysfunctional High Density Lipoprotein Scarb1 -/- Mouse Model (2022) (0)
Hepatic targeting and hypocholesterolemic effect of lactosaminated Fab against low density lipoproteins (1986) (0)
Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B100 ( atherosclerosis / protein polymorphism / cDNA sequence / protein secondary structure / lipid binding ) (0)
Serum opacity factor rescues fertility among female Scarb1−/− mice by reducing HDL-free cholesterol bioavailability (2022) (0)
Mono clonal antibodies against lipo protein lipase (1982) (0)
ARIC MANUSCRIPT PROPOSAL FORM Manuscript #104A 1. Title: Apolipoprotein E Genetic Polymorphism Predicts Carotid Artery Atherosclerosis Houston, TX 77225 2. Writing Group: (lead) (2001) (0)
RE 6 CENT STUDIES ON THE STRUCTURE OF IHUMVAN SERUMJ LOW-AND HIGH-DENSITY LIPOPROTEINS BY (0)
Normalizing effects of bacterial serum opacity factor on plasma lipids, tissues, and atherosclerosis (2022) (0)
Activation of PPAR{alpha} and PPAR{gamma} induce expression of the hepatic LDL receptor (2007) (0)
The role of receptors in biology and medicine : proceedings of the Ninth Argenteuil Symposium (1986) (0)
Structural Stability of Streptococcal Serum Opacity Factor (2017) (0)
The solid phase synthesis of a protein activator for lecithin-cholesterol acyltransferase corresponding to human plasma apoC-I ( solid-phase peptide synthesis / lipoproteins / phospholipid / circular dichroism / fluorescence / ultracentrifugation / lecithin : cholesterol acyltransferase ) (0)
ETAantagonist BQ123 inhibits endothelin-1-induced vasoconstriction in flow-loaded rabbit carotid, betic rat, and atherosclerotic human coronary arteries (1996) (0)
The Primary Structure of Human Plasma High Density Apolipoprotein Glutamine I ( ApoA-I ) II (2001) (0)
Abstract 394: Metabolic Insights into Age and Gender: A New Algorithm for Regional Body Mass Distribution (2013) (0)
Modulation of Triglyceride Metabolism by Diet and Drugs (1993) (0)
Apoprotein exchange between human high-density-lipoprotein subfractions (high-density-lipoprotein subfractions 2 and 3) [proceedings]. (1978) (0)
Background—It is unclear whether levels of high-density lipoprotein cholesterol (HDL-C) or apolipoprotein A-I (apoA-I) remain inversely associated with cardiovascular risk among patients who achieve very low levels of low-density lipoprotein cholesterol on statin therapy. It is also unknown whether (2013) (0)
Preparation and properties of an apoprotein derivative of human serum β-lipoprotein (1968) (0)
Partial delipidation of human serum beta-lipoprotein by sodium decyl sulfate. (1969) (0)
High Density Lipoprotein Therapies—Then and Now (2015) (0)
A Dual-Precipitation MethodEvaluated forMeasurement of Cholesterol in High-Density Lipoprotein Subfractions HDL2and HDL3in HumanPlasma (1989) (0)
The plasma metabolism of apolipoprotein A-IV (1987) (0)
Guest reviewers for volume 4 of the Journal of Behavioral Medicine (1981) (0)
Immunological Approach to Study the Structure of Oxidized Low Density Lipoproteins (1995) (0)
Isolation of Total RNA , Purification of Poly ( A ) RNA , and Northern Blotting (2004) (0)
Monoclonal Antibodies against Bovine Milk Lipoprotein Lipase CHARACTERIZATION OF AN ANTIBODY SPECIFIC FOR THE APOLIPOPROTEIN CI 1 BINDING SITE (2001) (0)
4P-0968 Pitavastatin down-regulates expression of the macrophages type B scavenger receptor, CD36 (2003) (0)
Abstract: P670 THE HEME-HEME OXYGENASE PATHWAY MODULATES INFLAMMATORY EICOSANOID SYNTHESIS IN VASCULAR CELLS (2009) (0)
Bacterial serum opacity factor catalyzes the discordant distribution of plasma proteins: Analysis by asymmetric flow flow-field fractionation (AF4) (2021) (0)
Structure and Functional Domains of Human Apolipoprotein B-100: A Strategy to Elucidate the Structure Information of a Large Protein (1989) (0)
LIPID-BINDING STUDIES IN THE HUMAN PLASMA LIPOPROTEINS (1977) (0)
The influence of dietary-fat saturation on the metabolism of apolipoproteins A-I, B and C in a type-IIb hyperlipoproteinaemic subject [proceedings]. (1978) (0)
Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclasses (1980) (0)
Studies on the Metabolism of Very Low Density Lipoprotein Using Pig Liver Perfusion (1979) (0)
Stability of streptococcal serum opacity factor, an HDL-disrupting protein. (2017) (0)
Effects of different statins on insulin storage and secretion from pancreatic β-cells: mechanisms and clinical implications. (2019) (0)
Effects of Lopid-SR on plasma lipids, lipoproteins and apolipoproteins in patient with combined hyperlipidemia and hypertriglyceridemia (1994) (0)
Physicochemical Factors in the Distribution of Plasma Lipoprotein Subunits between the Plasma Lipoproteins and the Arterial Wall (1978) (0)
Drugs Affecting High-Density Lipoprotein and Triglyceride Metabolism (1993) (0)
Endogenous scavenger receptor activity and baculovirus-mediated expression of the macrophage scavenger receptor in Sf-9 insect cells (1994) (0)
Neo HDL Produced by the Streptococcal Serum Opacity Factor Activity against Human High Density Lipoproteins is Hepatically Removed via Dual Mechanisms (2016) (0)
The HDL receptor, SR-B1, forms remnant HDL by a nibbling mechanism and releases apo AI. (2017) (0)
89 TANGIER DISEASE IN A BLACKMALE: AN UNUSUAL CLINICAL PRESENTATION (1990) (0)
Current concepts in reverse cholesterol transport (1990) (0)
We-W43:3 Activation of PPAR induces hepatic LDL receptor expression (2006) (0)
Elucidating the differential effects of statins on metabolism in pancreatic Β-cells cultured under high and low glucose (2022) (0)
Abstract 551: Is Free Cholesterol Bioavailability a Determinant of Dysfunctional, Atherogenic High Density Lipoproteins? Refining the Model of Reverse Cholesterol Transport (2018) (0)
Abstract 394: Bacterial Serum Opacity Factor Rescues HDL Functionality in SR-B1 -/- Mice (2018) (0)
Erratum: Locating a low density lipoprotein-targeting domain of human apolipoprotein B-100 by expressing a minigene construct in transgenic mice (Journal of Biological Chemistry (1991) 266 (20893-20898)) (1993) (0)
Regulation of CD36 by PPARγ: Pro- or Antiatherogenic? (2002) (0)
Mechanism of activation of human plasma lecithin cholesterol acyl transferase (1980) (0)
Stimulatory Effects of Inosine and Deoxyinosine on the Incorporation of @ 4C, @ â€˜IC,and @ â€˜ICinto Nucleic Acids by Ehrlich Ascites Tumor Cells in Vitro1 (2006) (0)
Thermodynamics and Mechanism of the Association of Plasma Apolipoproteins with Synthetic Phosphatidylcholines (1982) (0)
Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo. (2016) (0)
Regulation of hepatic lipoprotein biosynthesis by hormones (1990) (0)
The Structure of ApoB-100: Structure-Function Studies (1987) (0)
Primary Structure of Rabbit Apolipoprotein A-I High Performance Liquid Chromatography, PTC-Amino Acid Analysis, and Microsequencing (1986) (0)
MulticenterEvaluationof Reflotron#{174} DirectDry-Chemistry Assayof High-Density Lipoprotein Cholesterolin Venousand Fingerstick Specimens (1993) (0)
A comparison of two methods to investigate the metabolism of human apolipoproteins A-I and and A-I 1 (2002) (0)
Design issues when a second drug confounds effects of the primary treatment (1991) (0)
Apolipoprotein C-III, an important player in lipoprotein metabolism (1996) (0)
The role of hydrophobicity in the structure of the human plasma lipoproteins. (1985) (0)
Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and i nt race 1 I u lar I i pid accumulation (0)
by Hepatic Lipase (1984) (0)
Mono clonal antibodies to human apo lipo protein e (1982) (0)
Meeting Summary Workshop on Apolipoprotein Quantification (2005) (0)
Cellular ABCA1-derived nascent HDL-cholesterol Transfers to the LDLR pathway. (2017) (0)
Growth factor regulation of microvascular outgrowth from rabbit aortic explants (1994) (0)
The plasma lipoproteins: current concepts of metabolism and structure with clinical implications. (1978) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Antonio M. Jr. Gotto?

Antonio M. Jr. Gotto is affiliated with the following schools:

Antonio M. Jr. Gotto's Academic­Influence.com Rankings

Why Is Antonio M. Jr. Gotto Influential?

Antonio M. Jr. Gotto's Published Works

Published Works

What Schools Are Affiliated With Antonio M. Jr. Gotto?

Antonio M. Jr. Gotto's AcademicInfluence.com Rankings